ISAP Researchers' Profiles

Valerie Pearce Antonini, M.P.H.

Ms. Antonini has worked in the field of substance abuse and addiction since 1998. She is currently a project director at UCLA Integrated Substance Abuse Programs (UCLA-ISAP) overseeing several large-scale projects.  Over the course of her work with ISAP, she has led the implementation of a NIDA funded multi-site national methamphetamine medication-testing network (MCTG),  which was established in 2000 to investigate multiple protocols in various methamphetamine populations nationally, as well as contribute to the initiative of blending research and treatment philosophies.  Ms. Antonini has also been responsible for managing the day-to-day tasks involved in the multi-site 5-year telephone continuing care study entitled, “Four Models of Aftercare Support for Stimulant Abusers.”  She also has experience managing the development and implementation of 15 pilot studies under the California state initiative toward re-engineering the substance use treatment delivery toward a chronic care model and continuum of services.  In addition she has organized and facilitated several large scale trainings and conferences (national and international), has developed monitoring strategies, oversees compliance of regulatory requirements, can implement budget and contract guidelines, and has the capability to supervise day-to-day clinic activities to execute multiple and simultaneous project designs.

Education and Training

  • University of California, Los Angeles, M.P.H., 2007, Public Health
  • University of California, Los Angeles, B.A., 1996, Sociology

Specialties

  • Program management of large clinical trials, behavioral trials, and SUD service delivery improvement projects

  • Technical Assistance in regulatory affairs, good research practices, and implementation planning

Contact Info

Valerie Pearce Antonini, MPH
UCLA Integrated Substance Abuse Programs
11075 Santa Monica Blvd., Suite 100
Los Angeles, CA 90025
vpearce@mednet.ucla.edu

Selected Publications

  • D. Farabee, R. Rawson, M. Karno, V. Pearce, J. Brummer, S. Cousins, S. Patel. Continuing Care for Stimulant Recovery (CCSR): Four Models of Telephone Support for Stimulant Recovery. American Academy of Addiction Psychiatry, Coronado, SD, 2007 (Published in American Journal on Addiction, 1521-0391, Volume 17, Issue 4, 2008, Pages 328 – 340)

  • Rawson, R. Gonzales, R., Pearce, V., Marinelli-Casey, P., Ang, A, & Brummer, J. Methamphetamine Dependence and Human Immunodeficiency Virus Risk Behavior. Journal of Substance Abuse Treatment, 2008 Oct; 35 (3): 279-284. Epub 2008 Mar 7.

  • A. Elkashef , R. Rawson , E. Smith , V. Pearce , F. Flammino , J. Campbell , R. Donovick, C. Gorodetzky , W. Haning , J. Mawhinney , M. McCann , D. Weis , L. Williams , W. Ling, F. Vocci. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity. Addiction, 2007, 102, (Suppl. 1), 107–113.
  • AM Elkashef, R. Rawson, A. Anderson, S. Li, T. Holmes, E. Smith, N. Chiang, R. Kahn, F. Vocci, W. Ling, V. Pearce, M. McCann, J. Campbell, C. Gorodetzky, W. Haning, B. Carlton, J. Mawhinney, D, Weis. Bupropion for the Treatment of Methamphetamine Dependence. Neuropsychopharmacology advance online publication, 20 June 2007; doi:10.1038/sj.npp.1301481.

Last updated - 02/10/2012

Click here to view other profiles.

Top of Page